These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6600444)

  • 1. Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197.
    Anderson P
    Infect Immun; 1983 Jan; 39(1):233-8. PubMed ID: 6600444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197.
    Anderson P; Pichichero ME; Insel RA
    J Clin Invest; 1985 Jul; 76(1):52-9. PubMed ID: 3874882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic trimer and tetramer of 3-beta-D-ribose-(1-1)-D-ribitol-5-phosphate conjugated to protein induce antibody responses to Haemophilus influenzae type b capsular polysaccharide in mice and monkeys.
    Peeters CC; Evenberg D; Hoogerhout P; Käyhty H; Saarinen L; van Boeckel CA; van der Marel GA; van Boom JH; Poolman JT
    Infect Immun; 1992 May; 60(5):1826-33. PubMed ID: 1563770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant.
    Mariotti S; Teloni R; von Hunolstein C; Romagnoli G; Orefici G; Nisini R
    Vaccine; 2002 May; 20(17-18):2229-39. PubMed ID: 12009277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197.
    Anderson PW; Pichichero ME; Stein EC; Porcelli S; Betts RF; Connuck DM; Korones D; Insel RA; Zahradnik JM; Eby R
    J Immunol; 1989 Apr; 142(7):2464-8. PubMed ID: 2784464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemistry of some bacterial oligosaccharide protein conjugates.
    Costantino P; Viti S; Vannozzi F; Serafini G; Marsili I; Valeri A
    Ann Sclavo Collana Monogr; 1986; 3(1-2):359-66. PubMed ID: 3501300
    [No Abstract]   [Full Text] [Related]  

  • 7. Human antibody responses to two conjugate vaccines of Haemophilus influenzae type B saccharides and diphtheria toxin.
    Seppälä I; Sarvas H; Mäkelä O; Mattila P; Eskola J; Käyhty H
    Scand J Immunol; 1988 Oct; 28(4):471-9. PubMed ID: 3264084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
    Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
    Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.
    Chu C; Schneerson R; Robbins JB; Rastogi SC
    Infect Immun; 1983 Apr; 40(1):245-56. PubMed ID: 6601061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific antibodies to diphtheria toxin and type 6A pneumococcal capsular polysaccharide induced by a model of semi-synthetic glycoconjugate antigen.
    Porro M; Costantino P; Viti S; Vannozzi F; Naggi A; Torri G
    Mol Immunol; 1985 Aug; 22(8):907-19. PubMed ID: 4047043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.
    Granoff DM; Rathore MH; Holmes SJ; Granoff PD; Lucas AH
    Vaccine; 1993; 11 Suppl 1():S46-51. PubMed ID: 8447176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.
    Schneerson R; Barrera O; Sutton A; Robbins JB
    J Exp Med; 1980 Aug; 152(2):361-76. PubMed ID: 6967514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro induction of a Haemophilus influenzae type b polysaccharide-specific antibody response in human peripheral blood lymphocytes of individuals recently vaccinated with an oligosaccharide-protein conjugate.
    Peeters CC; Tenbergen-Meekes AM; Heijnen CJ; Poolman JT; Zegers BJ; Rijkers GT
    J Immunol; 1991 Dec; 147(12):4192-9. PubMed ID: 1753096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide.
    Schneider LC; Insel RA; Howie G; Madore DV; Geha RS
    J Allergy Clin Immunol; 1990 May; 85(5):948-53. PubMed ID: 2332568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.
    Schneerson R; Robbins JB; Chu C; Sutton A; Vann W; Vickers JC; London WT; Curfman B; Hardegree MC; Shiloach J
    Infect Immun; 1984 Sep; 45(3):582-91. PubMed ID: 6332076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines.
    Granoff DM; Holmes SJ; Osterholm MT; McHugh JE; Lucas AH; Anderson EL; Belshe RB; Jacobs JL; Medley F; Murphy TV
    J Infect Dis; 1993 Sep; 168(3):663-71. PubMed ID: 8354908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant.
    Anderson PW; Pichichero ME; Insel RA; Betts R; Eby R; Smith DH
    J Immunol; 1986 Aug; 137(4):1181-6. PubMed ID: 3016088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b.
    Anderson P; Pichichero ME; Insel RA
    J Pediatr; 1985 Sep; 107(3):346-51. PubMed ID: 3875705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
    Madore DV; Johnson CL; Phipps DC; Myers MG; Eby R; Smith DH
    Pediatrics; 1990 Oct; 86(4):527-34. PubMed ID: 2216616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.